Association of Klotho and interleukin 6 gene polymorphisms with aging in Han Chinese population

Journal of Nutrition, Health and Aging

Volumn 18, Issue 10, 2014, Pages 900-904

  Zhang, W G ^a   Bai, X J ^b   Chen, D P ^a   Lv, Y ^a   Sun, X F ^a   Cai, G Y ^a   Bai, X Y ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Aging; biological age; healthy; interleukin 6; Klotho; polymorphisms

Indexed keywords

BETA GLUCURONIDASE; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; KLOTHO PROTEIN;

ADULT; AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; GLUCURONIDASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84930007555     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-014-0470-z     Document Type: Article

References (34)

1. Gavrilov LA, Gavrilova NS (2001) The reliability theory of aging and longevity. Journal of theoretical Biology 213: 527–545.
2. Holliday R (2004) Aging: The Reality The Multiple and Irreversible Causes of Aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: B568–B572.
3. Mitteldorf J (2012) Adaptive aging in the context of evolutionary theory. Biochemistry (Moscow) 77: 716–725.
4. Martin G, Sprague C, Epstein C (1970) Replicative life-span of cultivated human cells. Effects of donor’s age, tissue, and genotype. Laboratory investigation; a journal of technical methods and pathology 23: 86.
5. Arking DE, Krebsova A, Macek M, et al (2002) Association of human aging with a functional variant of klotho. Proceedings of the National Academy of Sciences 99: 856–861.
6. Kurosu H, Yamamoto M, Clark JD, et al (2005) Suppression of aging in mice by the hormone Klotho. Science Signaling 309: 1829.
7. Hu MC, Shiizaki K, Kuro-o M, et al (2013) Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism. Physiology 75.
8. Vasto S, Candore G, Balistreri CR, et al (2007) Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 128: 83–91.
9. Hirano T (2010) The Biology of Interleukin-6 (Part 1 of 2).
10. Petersen AMW, Pedersen BK (2005) The anti-inflammatory effect of exercise. Journal of applied physiology 98: 1154–1162.
11. Singh T, Newman AB (2011) Inflammatory markers in population studies of aging. Ageing Res Rev 10: 319–329.
12. Mocchegiani E, Giacconi R, Costarelli L, et al. (2008) Zinc deficiency and IL-6-174G/C polymorphism in old people from different European countries: Effect of zinc supplementation. ZINCAGE study. Experimental gerontology 43: 433–444.
13. Pes G, Lio D, Carru C, et al (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging clinical and experimental research 16: 244.
14. Koh SJ, Jang Y, Hyun YJ, et al (2009) Interleukin-6 (IL-6) −572C—>G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Clin Endocrinol (Oxf) 70: 238–244.
15. Cederholm T, Persson M, Andersson P, et al (2007) Polymorphisms in cytokine genes influence long—term survival differently in elderly male and female patients. Journal of internal medicine 262: 215–223.
16. Kawano KI, Ogata N, Chiano M, et al (2002) Klotho gene polymorphisms associated with bone density of aged postmenopausal women. Journal of Bone and Mineral Research 17: 1744–1751.
17. Rhee E-J, Oh K-W, Lee W-Y, et al (2006) The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease. Metabolism: clinical and experimental 55: 1344.
18. Zhang WG, Bai XJ, Chen XM (2010) SIRT1 variants are associated with aging in a healthy Han Chinese population. Clin Chim Acta 411: 1679–1683.
19. http://www.scio.gov.cn/zfbps/ndhf/2006/200905/t307877.htm; 2006.
20. Barrett JC, Fry B, Maller J, et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
21. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: Cold spring harbor laboratory press New York.
22. Raymond M, Rousset F (1995) GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. Journal of heredity 86: 248–249.
23. Papaconstantinou J (2009) Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Molecular and cellular endocrinology 299: 89–100.
24. Semba RD, Cappola AR, Sun K, et al (2011) Plasma klotho and mortality risk in older community-dwelling adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66: 794–800.
25. Invidia L, Salvioli S, Altilia S, et al (2010) The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology 11: 67–73.
26. Zhang F, Kato BS, Gardner JP, et al (2007) Lack of association between leukocyte telomere length and genetic variants in two ageing-related candidate genes. Mechanisms of ageing and development 128: 415–422.
27. Rhee EJ, Oh KW, Lee WY, et al (2006) The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease. Metabolism 55: 1344–1351.
28. Jenny NS, French B, Arnold AM, et al (2012) Long-term Assessment of Inflammation and Healthy Aging in Late Life: The Cardiovascular Health Study All Stars. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 67: 970–976.
29. Eisenlohr-Moul T, Segerstrom S (2012) Autonomy, positive relationships, and IL-6: Evidence for gender-specific effects. British Journal of Health Psychology.
30. Di Bona D, Vasto S, Capurso C, et al (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing research reviews 8: 36.
31. Baune BT, Rothermundt M, Ladwig KH, et al (2011) Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. AGE 33: 209–217.
32. Zheng G, Chen H, Xiong SQ (2012) Polymorphisms of- 174G> C and- 572G> C in the Interleukin 6 (IL-6) Gene and Coronary Heart Disease Risk: A Meta-Analysis of 27 Research Studies. PloS one 7: e34839.
33. Chen SY, Chen TF, Lai LC, et al (2012) Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer’s disease. Journal of Neuroinflammation 9: 21.
34. Chen J, Liu RY, Yang L, et al (2012) A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk. Journal of Cancer Research and Clinical Oncology: 1–12.